The Board remands the claims for additional medical inquiry regarding whether medication used for service-connected heart disease aggravates upper and lower extremity peripheral neuropathy/radiculopathy.
The deciding factor: The May 2025 VA reports do not adequately address the specific question noted in the remand, which is whether medication would worsen either temporarily or permanently the radicular symptoms.
- Claimed conditions
- Peripheral neuropathy/radiculopathy in the right upper extremity, Peripheral neuropathy/radiculopathy in the left upper extremity, Peripheral neuropathy/radiculopathy in the right lower extremity, Peripheral neuropathy/radiculopathy in the left lower extremity
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- July 16, 2025
- Citation
- 25009256
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.